Lophora
PrivateLast Round
VC Round
Jan 15, 2025
Total Funding Raised
$2.2M
Company Overview
Lophora operates in Healthcare & Life Sciences and is based in Charlottenlund. Its latest recorded funding round was a VC Round in January 2025.
Lophora is a clinical-stage CNS therapeutics company developing differentiated, next-generation neuroactive medicines designed to induce neuroplasticity and address significant unmet needs in neuropsychiatry.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Mental Health, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lophora Comparables
Compare Lophora with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Delix Therapeutics | 89% | |
| Xylo Bio | 83% | |
| Reunion Neuroscience Inc. | 83% |
For institutional investors. Book with your work email.
Lophora Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jan 15, 2025 | ||||
| VC Round | Aug 24, 2023 | ||||
| VC Round | Mar 2, 2021 | ||||
| Grant | Mar 2, 2021 | ||||
| Convertible Debt | Apr 3, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Lophora Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovation Fund Denmark | Grant |
| Novo Nordisk Foundation | Convertible Debt |
| The Export and Investment Fund of Denmark | VC Round |
| BioInnovation Institute | Convertible Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 6, 2026
Monthly visitors grew 247% MoM, from 420 to 1.5K.
- Jan 14, 2025
Monthly visitors grew 247% MoM to 594.
For institutional investors. Book with your work email.
Lophora Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Lophora's valuation, stock price, and market status.
Is Lophora a public or private company?
Lophora is a private company.
What is the current stock price of Lophora?
Lophora is a private company, so its shares have no public market price. Caplight tracks Lophora's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Lophora worth (valuation)?
Valuation information for Lophora is not publicly available.
Can I buy Lophora stock?
Lophora shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Lophora's last funding round?
Lophora's most recent funding round was VC Round on January 15, 2025.
Who are the main investors in Lophora?
Key investors in Lophora include Innovation Fund Denmark, Novo Nordisk Foundation, The Export and Investment Fund of Denmark, BioInnovation Institute.
Will Lophora IPO soon?
No public IPO plans have been announced for Lophora.
How can I track Lophora secondary market activity?
Caplight tracks bids, offers, and trades in Lophora's shares on secondary markets.